600 filings
Page 11 of 30
8-K
xh61nrc5b52 ad3g05
7 Nov 19
Catalyst Biosciences Reports Third Quarter 2019 Operating & Financial Results and Provides a Corporate Update
8:00am
8-K
3tglg0fdexz
15 Oct 19
Entry into a Material Definitive Agreement
2:10pm
8-K
h84doiqub6v c7uy6ldy
3 Oct 19
Catalyst Biosciences Provides DalcA Phase 2b Trial Update
8:05am
8-K
8ttekwoav33do2svken
29 Aug 19
Catalyst Biosciences Announces Transition of Chief Financial Officer
5:00pm
8-K
0l4 1fnu7gvm3wp
1 Aug 19
Results of Operations and Financial Condition
4:10pm
8-K
pzpmvc4dh8i 1t
17 Jun 19
Submission of Matters to a Vote of Security Holders
5:00pm
DEFA14A
d9cfyzcpnq5
2 May 19
Additional proxy soliciting materials
3:02pm
8-K
9yp5fm
2 May 19
Results of Operations and Financial Condition
8:01am
8-K
t8od5qr00anwtort
2 Apr 19
Catalyst Biosciences Receives Orphan Designation from the European
4:18pm
8-K
vrg ktgj49
7 Mar 19
Financial Results and Provides a Corporate Update
4:11pm
EFFECT
bgt7yrn5g6l3
14 Feb 19
Notice of effectiveness
12:00am
CORRESP
ce1cxer2k8d9
11 Feb 19
Correspondence with SEC
12:00am
UPLOAD
7x1v3zkufebgwf
8 Feb 19
Letter from SEC
12:00am
8-K
xes89x w0
25 Jan 19
Departure of Directors or Certain Officers
4:50pm